Radiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

DOI: 10.1148/radiol.2402050223
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by de Vries, M.
Right arrow Articles by de Haan, M. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by de Vries, M.
Right arrow Articles by de Haan, M. W.
(Radiology 2006;240:401-410.)
© RSNA, 2006

Evidence-Based Practice

Peripheral Arterial Disease: Clinical and Cost Comparisons between Duplex US and Contrast-enhanced MR Angiography—A Multicenter Randomized Trial1

Marianne de Vries, MD, Rody Ouwendijk, MD, Karin Flobbe, PhD, Patricia J. Nelemans, MD, PhD, Alphons G. Kessels, MD, MSc, GeertWillem H. Schurink, MD, PhD, J. Adam van der Vliet, MD, PhD, Frans M. J. Heijstraten, MD, PhD, Philippe W. M. Cuypers, MD, PhD, Lucien E. M. Duijm, MD, PhD, Jos M. A. van Engelshoven, MD, PhD, M. G. Myriam Hunink, MD, PhD and Michiel W. de Haan, MD, PhD

1 From the Departments of Radiology (M.d.V., K.F., J.M.A.v.E., M.W.d.H.), Epidemiology (P.J.N.), Clinical Epidemiology and Medical Technology Assessment (A.G.K.), and Vascular Surgery (G.H.S.) and Cardiovascular Research Institute Maastricht (M.d.V., G.H.S., J.M.A.v.E., M.W.d.H.), Maastricht University MC, P. Debyeplein 25, 6202 AZ Maastricht, the Netherlands; Departments of Radiology (R.O., M.G.M.H.) and Epidemiology and Biostatistics (R.O., M.G.M.H.), Erasmus MC Rotterdam, Rotterdam, the Netherlands; Departments of Vascular Surgery (J.A.v.d.V.) and Radiology (F.M.J.H.), University Medical Ctr, Nijmegen, the Netherlands; and Departments of Vascular Surgery (P.W.M.C.) and Radiology (L.E.M.D.), St Catharina Hospital, Eindhoven, the Netherlands. Received February 9, 2005; revision requested April 8; revision received May 29; accepted June 21; final version accepted October 4. Supported by the Netherlands Organization for Health Research and Development. Address correspondence to M.d.V. (e-mail: mdvr{at}rdia.azm.nl).

Purpose: To prospectively determine the clinical and economic consequences of replacing duplex ultrasonography (US) with contrast material–enhanced magnetic resonance (MR) angiography for the initial imaging work-up of patients with peripheral arterial disease (PAD).

Materials and Methods: This randomized multicenter study was approved by the institutional review board of each hospital, and all patients signed written informed consent prior to randomization. Patients with PAD who needed to undergo imaging work-up and who had an ankle-brachial pressure index (ABPI) of less than 0.90 were recruited by vascular surgeons between January 2002 and September 2003. Patients were randomly assigned to undergo contrast-enhanced MR angiography or duplex US. The primary outcome measure was cost. Secondary outcome measures included therapeutic confidence, changes in disease severity, and changes in quality of life (QOL) assessed during 6 months of follow-up. Indicators for disease severity were based on the Rutherford classification, treadmill walking distance, ABPI at rest, and ABPI after exercise. QOL was assessed with the Rating Scale, Short Form 36, EuroQol-5D, and VascuQol questionnaires. The cost of (additional) imaging procedures, therapeutic interventions, and outpatient visits were calculated from a hospital perspective (ie, all costs incurred inside the hospital were estimated, including physician costs). Data were evaluated by using the Student t test and a multivariable linear regression analysis.

Results: At 6 months, 352 patients (239 [68%] men, 113 [32%] women; mean age, 65 years) were analyzed. The use of contrast-enhanced MR angiography versus duplex US reduced the number of additional vascular imaging procedures by 42%; contrast-enhanced MR angiography was also associated with higher therapeutic confidence. Diagnostic costs for contrast-enhanced MR angiography were {euro}167 ($186) higher than those for duplex US (P < .001). No statistically significant differences were found for total cost, changes in disease severity, or changes in QOL between patients examined with duplex US and those examined with contrast-enhanced MR angiography (P > .05).

Conclusion: Replacing duplex US with contrast-enhanced MR angiography for the initial imaging work-up of patients with PAD reduces the need for additional imaging, although diagnostic costs are higher.

© RSNA, 2006




This article has been cited by other articles:


Home page
 Am. J. Roentgenol.Home page
R. Ouwendijk, M. de Vries, T. Stijnen, P. M. T. Pattynama, M. R. H. M. van Sambeek, J. Buth, A. V. Tielbeek, D. A. van der Vliet, L. J. SchutzeKool, P. J. E. H. M. Kitslaar, et al.
Multicenter Randomized Controlled Trial of the Costs and Effects of Noninvasive Diagnostic Imaging in Patients with Peripheral Arterial Disease: The DIPAD Trial
Am. J. Roentgenol., May 1, 2008; 190(5): 1349 - 1357.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
RADIOLOGY RADIOGRAPHICS RSNA JOURNALS ONLINE
Copyright © 2006 by the Radiological Society of North America.